CD4 and nervous system disorder: We initially investigated the expression of Ki-67, HLA-DR and CD38 on CD4+ T cells in PBMC from healthy donors (Control), HTLV-1 infected patients who were clinically asymptomatic (HTLV), or had associated neurological disease (HAM/TSP).